ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Feb 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
January 2026
Latest News
Fusion energy: Progress, partnerships, and the path to deployment
Over the past decade, fusion energy has moved decisively from scientific aspiration toward a credible pathway to a new energy technology. Thanks to long-term federal support, we have significantly advanced our fundamental understanding of plasma physics—the behavior of the superheated gases at the heart of fusion devices. This knowledge will enable the creation and control of fusion fuel under conditions required for future power plants. Our progress is exemplified by breakthroughs at the National Ignition Facility and the Joint European Torus.
B.F. Peterman, J.R. Johnson, R.G.C. McElroy
Fusion Science and Technology | Volume 8 | Number 2 | September 1985 | Pages 2557-2563
Environmental Study | Proceedings of the Second National Topical Meeting on Tritium Technology in Fission, Fusion and Isotopic Applications (Dayton, Ohio, April 30 to May 2, 1985) | doi.org/10.13182/FST85-A24664
Articles are hosted by Taylor and Francis Online.
This paper describes a study on metabolism of inhaled tritiated hydrogen gas (HT) in mammals. Rats and human volunteers were exposed to HT gas for periods from one minute to ten minutes. The amount of HT that was oxidized in vivo was estimated by measuring the concentration of HTO in urine. No significant quantities of tritiated organic compounds resulting from HT gas inhalation were observed in tissues of rats and it is assumed that this holds true for humans also. The fraction of inhaled HT converted to HTO in human volunteers was found to be about 1 × 10−4 indicating that the dose from the HTO that resulted from HT oxidiation is a significant component of the effective dose equivalent.